Kotak 
Dealstreet

Kotak PE invests 400 crore in Biorad Medisys: Luthra advises

Kotak Strategic Situations India Fund II invested ₹400 crore.

Bar & Bench

Kotak Strategic Situations India Fund II, managed by Kotak Alternate Asset Managers Limited, has made an investment of up to ₹400 Crore in medical device manufacturer Biorad Medisys Private Limited.

Luthra and Luthra Law Offices India represented Kotak in this investment deal.

The transaction team consisted of Nishant Singh (Partner), Prachi Pandit (Managing Associate), Saksham Madan (Managing Associate), Manushi Shah (Associate), Varshini Ramesh (Associate), Aditi Nagpal (Associate), Charith Reddy (Associate), Kashish Singhal (Associate), Maitri Meghani (Associate) and Aashi Shah (Associate).

Nishant Singh

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Internship: A comedy of errors

Allahabad High Court reunites interfaith couple, pulls up UP police for their unlawful detention

Kerala High Court helps drug addict NDPS accused secure college admission; pays his course fee

NLU Consortium expert committee invites public comments for CLAT 2027

Delhi High Court protects personality rights of singer Kumar Sanu

SCROLL FOR NEXT